Novartis Looks to Buy French Firm to Bolster Cancer Portfolio

[ad_1]

The $3.9 billion acquisition of Advanced Accelerator Applications would mark a rare deal in the pharmaceutical sector this year.

[ad_2]

Source link
This is from today’s news)